SLC7A11 and hepatocellular carcinoma: We observed a consistent tendency, which indicated that elevated SLC7A11 expression levels were associated with overall survival and recurrence-free survival, and the differences were statistically significant (Figure 1F,G), suggesting that SLC7A11 is a potential prognostic biomarker that contributes to the progression of HCC.